Mostrar Notícias:

ABTPrincipaisÚltima HoraBovespa - Brasil

 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Abbott Laboratori (ordenadas pela data):

The Money Times

Should the FDA Have Moved Faster on Abbott's Diet Pill? Seeking Alpha (blog) The SCOUT study, which was financed by Abbott Labs (ABT), the company that sells the pill, shows Meridia raised heart attack and stroke risk in patients ... NEJM fuels calls to withdraw Abbott's MeridiaFiercePharma Journal editors question sale of diet pill MeridiaForbes all 302 news articles »

Abbott Laboratories (NYSE:ABT) New Product Stock Briefings (blog) A Hepatitis B test has been approved by the Federal Drug Administration, Abbott Laboratories (NYSE:ABT) has reported. While controversies and recalls over ... Abbott RealTime HBV assay receives marketing approval from FDANews-Medical.net all 10 news articles »

Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging ... MarketWatch (press release) ... on the major drug manufacturers industry and has completed analytical research on GlaxoSmithKline (NYSE:GSK) and Abbott Laboratories (NYSE:ABT) . ... Abbott Laboratories (ABT) Breaks Through Support at $49.29Comtex Smartrend Resistance Above for Abbott Labs?TradersHuddle.com ABBOTT LABORATORIES (ABT) BREAKS THROUGH SUPPORT AT $49.29Zacks.com all 16 news articles »

Abbott Receives FDA Approval for First Automated Molecular Test for Assessing ... PR Newswire (press release) 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it has received approval from the US Food and Drug Administration (FDA) to market the Abbott ... Abbott Gets FDA Approval For First Automated Molecular Test To Assess ...RTT News all 27 news articles »

Abbott Recalls Lens Solutions In Parts Of Europe, Middle East Wall Street Journal Abbott Laboratories (ABT) has recalled bottles of two contact lens solutions in parts of Europe and the Middle East ... and more »

News and FDA Updates for Abbott (NYSE:ABT), ADVENTRX (NYSE:ANX), AmStem (OTC:AMST) American Chronicle On 09/01/10, Abbott (NYSE:ABT) announced it has received approval from the US Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for ...

Analysis: Genzyme units attract interest, what about Sanofi? Reuters N) and large drug companies such as Abbott Laboratories (ABT.N). Suitors from outside the industry but who have a hand in healthcare could also show ... and more »

News and FDA Updates for Abbott (NYSE:ABT), Anavex (OTC:AVXL), BioDelivery ... American Chronicle On 08/30/10, Abbott (NYSE:ABT) will present at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 13, 2010. On 08/30/10, ... and more »

Orexigen, Takeda in $1 bln deal for obesity drug Reuters The mid-September Arena panel review will follow a hearing on Meridia, a diet drug sold by Abbott Laboratories (ABT.N) that has been pulled from the market ... and more »

Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference TTKN News Abbott Park, Illinois (NYSE: ABT) ? Abbott will present at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 13, 2010. ... and more »

Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference PR Newswire (press release) 30 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) will present at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, Sept. 13, 2010. ... and more »

Crain's Chicago Business

CEO Is Latest Hospira Exec Hitting The Road Forbes Begley has been at the helm of the company for six years, since he led the company in its spin-off from Abbott Laboratories ( ABT - news - people ). ... Hospira (HSP) Shares Fall as CEO/Chairman and COO Announce RetirementStreetInsider.com (subscription) Hospira CEO retiring: Christopher Begley has been drugmaker's only chief executiveTrading Markets (press release) Hospira CEO Christopher Begley To Step Down - UpdateRTT News all 67 news articles »

Local Dancers Shine in FSPA Summer Dance Concert Broadway World Madeux-Abbott danced previously with the American Ballet Theatre, and taught the Young Dancers Program at ABT this past summer. Madeux Abbott said the ...

5 Safe Stocks for the Next Market Crash StreetAuthority Abbott Laboratories (NYSE: ABT) deserves a look solely for the strength of its dividend yield, currently about 3.5%, after a +10% dividend increase this ...

Casey's, Intel, Jos. A. Bank, Sunrise: US Equity Movers Bloomberg Abbott Laboratories (ABT US) added 1.9 percent to $50.27 for the biggest gain since July 21. The Food and Drug Administration approved the drugmaker's ... and more »

David Margolis' Fight to End AIDS BusinessWeek His earlier study using Abbott Laboratories' (ABT) bipolar disorder drug Depakote yielded promising results, which Margolis and others disproved. ...

Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging ... PR-USA.net (press release) ... on the major drug manufacturers industry and has completed analytical research on GlaxoSmithKline ( NYSE : GSK ) and Abbott Laboratories ( NYSE : ABT ). ... and more »

4 Stocks For An Uncertain Market Investopedia Abbott Labs (NYSE:ABT) is a popular name, and with good reason. The company is diversified across drugs, diagnostics and devices, and management has been ...

Abbott Provides Initial Support for Flood Relief Efforts in Pakistan TTKN News Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and ... and more »

Herbert A. Fritsche, Ph.D., Former MD Anderson Cancer Center Professor and ... National Post (registration) (blog) The Company also entered into royalty-bearing licenses for its tissue biopsy-based prostate cancer test with Abbott Laboratories (NYSE: ABT) for development ... and more »

A Cautionary Tale For Bubblicious Portfolios istockAnalyst.com (press release) You can pull up the charts for the other pharmaceutical giants, then and now, like Pfizer (PFE), Abbott Labs (ABT), Novatis (NVS), etc. and find the same ... and more »

Good Setup in Abbott Labs TradersHuddle.com New York, August 26th (TradersHuddle.com) - Shares of Abbott Laboratories (NYSE:ABT) closed the trading session at $49.82 near its 50 day and 200 day moving ... Watch for Shares of Abbott Laboratories (ABT) to Approach Resistance at $50.15Benzinga WATCH FOR SHARES OF ABBOTT LABORATORIES (ABT) TO APPROACH RESISTANCE AT $50.15Zacks.com all 7 news articles »

Stock Update on ABT, LSTR and NWTT From PennyToBuck.com Penny Stock Live (blog) The Abbott Fund is helping reverse this trend by supporting California's Healthcare Laboratory Workforce Initiative (HLWI), which has helped to more than ...

Abbott Laboratories (NYSE:ABT) Terminate Agreement Stock Briefings (blog) In the passing of rights back to SkyePharma, Abbott Laboratories (NYSE:ABT) has terminated the agreement between the two companies. ... SkyePharma regains US marketing rights to Flutiform from AbbottThe Pharma Letter all 7 news articles »

Stock Update On PROT, PWRM, ABT From PennyToBuck.com Penny Stock Live (blog) The Abbott Fund is helping reverse this trend by supporting California's Healthcare Laboratory Workforce Initiative (HLWI), which has helped to more than ... and more »

NICE Recommends 6 Treatments For Rheumatoid Arthritis Wall Street Journal Abbott Laboratories's (ABT) adalimumab is marketed as Humira while Pfizer's etanercept is called Enbrel. The brand name of Merck & Co's (MRK) infliximab is ... and more »

ABBOTT LABORATORIES RISES 1.88% ON HEAVY VOLUME: WATCH FOR PULLBACK (ABT) Zacks.com Sep 02, 2010 (SmarTrend(R) News Watch via COMTEX) -- Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $49.72 to a high ... and more »

Abbott Laboratories In Review: Shares Trading 10.90% Above its May 6th Crash ... Comtex Smartrend Abbott Laboratories (NYSE:ABT) is currently trading 10.90% above its May 6th low of $45.60. Investors are looking to see if this 'flash crash' ... and more »

Indicated Dividend Yield Ranking for the S&P 500 by Industry Bloomberg ... 4.38 0.38 156.8 JNJ Johnson & Johnson 3.77 0.54 43.2 ABT Abbott Laboratories 3.56 0.44 52.6 PKI PerkinElmer Inc 1.33 0.07 15.3 AGN Allergan Inc/United ... and more »

A Recall a Week, That's All We Ask Motley Fool Will doctors start recommending Abbott Labs' (NYSE: ABT) Humira or Pfizer (NYSE: PFE) and Amgen's (Nasdaq: AMGN) Enbrel over Johnson & Johnson's (NYSE: JNJ) ... and more »